Skip to main content
Premium Trial:

Request an Annual Quote

David Schreiber, Peter Boatright, Tim McGrath

Premium

Nanogen has appointed David Schreiber director, and re-elected Stelios Papadopoulos to a second term during the company’s annual stockholders’ meeting. Both board members will serve three-year terms. Papadopoulos has been a Nanogen director since 1999.

Schreiber most recently served as senior vice president and CFO of Dianon Systems, a company acquired by the Laboratory Corporation of America.


Lark Technologies has appointed Peter Boatright and Tim McGrath to its board of directors.

Both men will serve until August, at which time they will run for election to the board for a one-year term. The new appointees also represent an expansion of the board from four to six members, and increase the number of independent board members from one to three.

McGrath is currently CEO for microarray-tools company Xeotron. He is also a former president of Sigma-Genosys. Prior to Genosys, McGrath held sales and marketing positions at Millipore, Zymark, and Beckman Instruments.

Boatright, meantime, is a semi-retired attorney and certified public accountant. He currently serves on the board of the Oklahoma United Methodist Foundation and is chairman of its investment committee. Boatright also serves on the board of Guaranty Credit Card and Americrest Bank in Oklahoma City, where he is chairman of the audit committee.

 

Filed under

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.